These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7582074)

  • 1. Vascular remodeling in hypertension: role of autocrine-paracrine factors.
    Gibbons GH
    Blood Press Suppl; 1995; 2():49-54. PubMed ID: 7582074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition and vascular structure in hypertension.
    Gibbons GH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S19-24. PubMed ID: 1725196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide.
    Gibbons GH
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium and growth factors in vascular remodeling of hypertension.
    Dzau VJ; Gibbons GH
    Hypertension; 1991 Nov; 18(5 Suppl):III115-21. PubMed ID: 1937673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and cellular mechanisms regulating vascular function and structure--implications in the pathogenesis of hypertension.
    Touyz RM
    Can J Cardiol; 2000 Sep; 16(9):1137-46. PubMed ID: 11021957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine-paracrine factors and vascular remodeling in hypertension.
    Gibbons GH
    Curr Opin Nephrol Hypertens; 1993 Mar; 2(2):291-8. PubMed ID: 7922189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adventitial fibroblasts in vascular structure and function: the role of oxidative stress and beyond.
    Di Wang H; Rätsep MT; Chapman A; Boyd R
    Can J Physiol Pharmacol; 2010 Mar; 88(3):177-86. PubMed ID: 20393583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence in vivo for induction of cardiovascular growth processes by vasoconstrictor systems.
    Adams MA; Thompson KE; Banting JD; Madigan MA; Friberg P
    Blood Press Suppl; 1995; 2():61-7. PubMed ID: 7582078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular remodeling: mechanisms and implications.
    Dzau VJ; Gibbons GH
    J Cardiovasc Pharmacol; 1993; 21 Suppl 1():S1-5. PubMed ID: 7681124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors and vascular wall.
    Chabrier PE
    Int Angiol; 1996 Jun; 15(2):100-3. PubMed ID: 8803632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factors and the vessel wall.
    Corson MA; Berk BC
    Heart Dis Stroke; 1993; 2(2):166-70. PubMed ID: 8149104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular hypertrophy and hypertension: a role for growth factors?
    Lyall F; Lever AF; Morton JJ
    Acta Physiol Scand Suppl; 1988; 571():189-96. PubMed ID: 3239408
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin-converting enzyme and vascular remodeling.
    Heeneman S; Sluimer JC; Daemen MJ
    Circ Res; 2007 Aug; 101(5):441-54. PubMed ID: 17761934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging concepts in antihypertensive therapy: the benefits of angiotensin II blockade.
    Meggs LG; Kodali P
    J Assoc Acad Minor Phys; 1999; 10(2):34-43. PubMed ID: 10826007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.
    Touyz RM
    Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of vascular hypertrophy in hypertension].
    Tedgui A
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():67-72. PubMed ID: 8215782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and vascular wall remodeling in hypertension.
    Hamet P; deBlois D; Dam TV; Richard L; Teiger E; Tea BS; Orlov SN; Tremblay J
    Can J Physiol Pharmacol; 1996 Jul; 74(7):850-61. PubMed ID: 8946072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide, salt sensitivity, and cardiorenal injury in hypertension.
    Raij L
    Semin Nephrol; 1999 May; 19(3):296-303. PubMed ID: 10226336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.